BioSpecifics Technologies (BSTC) Has Risen 3% in Last One Year, Underperforms Market
If you are looking for the best ideas for your portfolio you may want to consider some of Summers Value Partners top stock picks.
Biospecifics Technologies Corp (BSTC)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Matarin Capital Valerie Malter | 0 | $0 | 0% | |
| 2. | Royce & Associates Chuck Royce | 0 | $0 | 0% | |
| 3. | Renaissance Technologies Jim Simons | 0 | $0 | 0% | |
| 4. | Contrarius Investment Management Stephen Mildenhall | 0 | $0 | 0% | |
| 5. | Winton Capital Management David Harding | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $88.50 | 7,344,955 | Large Shareholder | 100 | 2020-12-02 | Filing | |
| $47.83 | 696 | Other | 508,656 | 2015-11-25 | Filing | |
| $48.24 | 1,026 | Other | 507,960 | 2015-11-25 | Filing | |
| $48.20 | 2,000 | Other | 506,934 | 2015-11-25 | Filing | |
| $48.47 | 974 | Other | 504,934 | 2015-11-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.16 | 8,900 | Large Shareholder, Director | 935,073 | 2019-09-10 | Filing | |
| $55.23 | 1,100 | Large Shareholder, Director | 943,973 | 2019-09-09 | Filing | |
| $58.55 | 459 | Director | 30 | 2019-06-07 | Filing | |
| $57.25 | 500 | Director | 489 | 2019-06-05 | Filing | |
| $58.01 | 2,411 | Director | 989 | 2019-06-05 | Filing |
Institutional Investors' Holdings
News See All
Why BioSpecifics Technologies (BSTC) Stock is a Compelling Investment Case
Summers Value Partners recently released its Q2 2020 Investor Letter, a copy of which you can download here.
Hedge Funds Souring On BioSpecifics Technologies Corp. (BSTC)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Have Never Been More Bullish On BioSpecifics Technologies Corp. (BSTC)
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge ...
Here's What Hedge Funds Think About BioSpecifics Technologies Corp. (BSTC)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Hedge Funds Have Never Been This Bullish On BioSpecifics Technologies Corp. (BSTC)
The government requires hedge funds and wealthy investors that crossed the $100 million equity holdings threshold are required to file a report that shows their positions at the end of every quarter.
Hedge Funds Have Never Been More Bullish On BioSpecifics Technologies Corp. (BSTC)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...
Is BioSpecifics Technologies Corp. (NASDAQ:BSTC) Worthy of Your Portfolio?
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the SEC.
Is BioSpecifics Technologies Corp. (BSTC) A Good Stock To Buy Right Now?
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September 30.
Do These Companies' Insiders Fear A Grim Future For Their Stocks?
Insider selling has been more prominent than insider buying over the last several months, which could somewhat suggest that insiders do not foresee strong upside for their companies or at least the market...